Whole blood sample stability as an analytical parameter should be assessed when developing pharmacodynamic flow cytometry assays. Sample stability will determine the robustness of detecting not only ...

High-parameter (greater than 20-color) flow cytometry is increasingly adopted in clinical settings. It provides unparalleled capabilities for immunophenotypic characterization in the diagnosis of ...

Becton, Dickinson and Company BDX, popularly known as BD, recently announced the worldwide commercial launch of a new automated instrument, BD FACSDuet Premium Sample Preparation System. It prepares ...

Integrates state-of-the-art flow cytometry clinical trial services with leading genomics, proteomics, and molecular pathology solutions under one roof HUNTSVILLE, Ala., July 11, 2023 /PRNewswire/ -- ...

Becton, Dickinson and Company BDX, popularly known as BD, recently announced a strategic collaboration with Navigate BioPharma Services, Inc. The tie-up is aimed at exploring opportunities to develop ...

Flow cytometry has become a key analytical technique in clinical trials. Through its multiparametric analysis, single-cell resolution, and high-throughput evaluation capabilities, flow cytometry can ...

Myelodysplastic syndromes (MDS) describe cancers resulting from abnormal cells in the bone marrow. The abnormal bone marrow cells generate defective blood cells, which die earlier than normal blood ...

The following companies offer flow cytometry instruments, equipment, and/or reagents for clinical and laboratory purposes. Please contact the companies directly for more information concerning ...